Ajax loader

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: GlaxoSmithKline

GSK-RESULTS/
RTSABCZ1 
August 10, 2022 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration... 
Zenica, Bosnia and Herzegovina 
Illustration shows GSK (GlaxoSmithKline) logo 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration 
GSK-RESULTS/
RTSABCYZ 
August 10, 2022 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration... 
Zenica, Bosnia and Herzegovina 
Illustration shows GSK (GlaxoSmithKline) logo 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration 
GSK-RESULTS/
RTSABCYY 
August 10, 2022 
GSK (GlaxoSmithKline) logo and rising stock graph are seen in this illustration, August 10, 2022. REUTERS/Dado... 
Zenica, Bosnia and Herzegovina 
Illustration shows GSK (GlaxoSmithKline) logo and rising stock graph 
GSK (GlaxoSmithKline) logo and rising stock graph are seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration 
GSK-RESULTS/
RTSABCXH 
August 10, 2022 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration... 
Zenica, Bosnia and Herzegovina 
Illustration shows GSK (GlaxoSmithKline) logo 
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration 
GSK-M&A/UNILEVER
RTS4LL6U 
January 17, 2022 
A detail view of the exterior of the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah... 
London, United Kingdom 
Unilever signals it will pursue a deal for GlaxoSmithKline 
A detail view of the exterior of the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LL5J 
January 17, 2022 
A London Black Cab passes the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah... 
London, United Kingdom 
Unilever signals it will pursue a deal for GlaxoSmithKline 
A London Black Cab passes the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LL45 
January 17, 2022 
People walk past the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
Unilever signals it will pursue a deal for GlaxoSmithKline 
People walk past the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LL43 
January 17, 2022 
A person walks past the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay... 
London, United Kingdom 
Unilever signals it will pursue a deal for GlaxoSmithKline 
A person walks past the Unilever headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER-CONSUMER HEALTH
RTS4LJPP 
January 17, 2022 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
View of GlaxoSmithKline headquarters in London 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LIFS 
January 17, 2022 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
View of GlaxoSmithKline headquarters in London 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LIFT 
January 17, 2022 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
View of GlaxoSmithKline headquarters in London 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LIFU 
January 17, 2022 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
View of GlaxoSmithKline headquarters in London 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
GSK-M&A/UNILEVER
RTS4LIFV 
January 17, 2022 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
London, United Kingdom 
View of GlaxoSmithKline headquarters in London 
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022.REUTERS/Hannah McKay 
HEALTH-CORONAVIRUS/FRANCE-ICU
RTXBZY7A 
May 04, 2021 
GlaxoSmithKline's (GSK) drug, Augmentin, is seen in the COVID-19 Intensive Care Unit (ICU) at the Centre... 
Saint-Denis, France 
Intensive care unit at the Centre Cardiologique du Nord private hospital in Saint-Denis near Paris 
GlaxoSmithKline's (GSK) drug, Augmentin, is seen in the COVID-19 Intensive Care Unit (ICU) at the Centre Cardiologique du Nord private hospital in Saint-Denis, near Paris, amid the coronavirus disease pandemic in France, May 4, 2021. REUTERS/Benoit Tessier 
CHINA-TRADE/EXPO
RTX87CCX 
November 05, 2020 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China... 
Shanghai, China 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China November 5, 2020. REUTERS/Aly Song 
CHINA-TRADE/EXPO
RTX87CCV 
November 05, 2020 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China... 
Shanghai, China 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China November 5, 2020. REUTERS/Aly Song 
CHINA-TRADE/EXPO
RTX87CCP 
November 05, 2020 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China... 
Shanghai, China 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai 
GlaxoSmithKline (GSK) sign is seen at the third China International Import Expo (CIIE) in Shanghai, China November 5, 2020. REUTERS/Aly Song 
GSK-RESULTS/
RTX855HV 
October 26, 2020 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October... 
STEVENAGE, United Kingdom 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs 
GSK-RESULTS/
RTX855HN 
October 26, 2020 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October... 
STEVENAGE, United Kingdom 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility 
Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs 
HEALTH-CORONAVIRUS/USA
RTX7J4WY 
May 15, 2020 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the... 
Washington, UNITED STATES 
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington... 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, speaks as U.S. President Donald Trump listens during a coronavirus disease response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque 
HEALTH-CORONAVIRUS/USA
RTX7J4JL 
May 15, 2020 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the... 
Washington, UNITED STATES 
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington... 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, adjusts his protective face mask after speaking as President Donald Trump holds a coronavirus disease vaccine event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque 
HEALTH-CORONAVIRUS/USA
RTX7J4J2 
May 15, 2020 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the... 
Washington, UNITED STATES 
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington... 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, listens while wearing a protective face mask as President Donald Trump holds a coronavirus disease vaccine event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque 
HEALTH-CORONAVIRUS/USA
RTX7J4IH 
May 15, 2020 
U.S. President Donald Trump passes former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who... 
Washington, UNITED STATES 
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington... 
U.S. President Donald Trump passes former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, as he removes his face mask to speak during a coronavirus response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque 
HEALTH-CORONAVIRUS/USA
RTX7J4BT 
May 15, 2020 
U.S. President Donald Trump looks on as former GlaxoSmithKline pharmaceutical executive Moncef Slaoui,... 
Washington, UNITED STATES 
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington... 
U.S. President Donald Trump looks on as former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, removes his face mask during a coronavirus response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque 
HEALTH-CORONAVIRUS/USA
RTX7J4BR 
May 15, 2020 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the... 
Washington, UNITED STATES 
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington... 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, adjusts his protective face mask after speaking as President Donald Trump holds a coronavirus disease response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque 
HEALTH-CORONAVIRUS/USA
RTX7J4B8 
May 15, 2020 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the... 
Washington, UNITED STATES 
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington... 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, waits to speak as President Donald Trump holds a coronavirus disease response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque 
HEALTH-CORONAVIRUS/USA
RTX7J4B2 
May 15, 2020 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the... 
Washington, UNITED STATES 
U.S. President Trump holds coronavirus response event in the Rose Garden at the White House in Washington... 
Former GlaxoSmithKline pharmaceutical executive Moncef Slaoui, who will serve as chief adviser on the effort to find a vaccine for the coronavirus disease (COVID-19) pandemic, speaks as President Donald Trump listens during a coronavirus disease response event in the Rose Garden at the White House in Washington, U.S., May 15, 2020. REUTERS/Kevin Lamarque 
HEALTH-CORONAVIRUS/BRITAIN
RTX7HC7U 
May 05, 2020 
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West... 
London, United Kingdom 
Outbreak of the coronavirus disease (COVID-19) in London 
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville 
HEALTH-CORONAVIRUS/BRITAIN
RTX7HC7M 
May 05, 2020 
A general view outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following... 
London, United Kingdom 
Outbreak of the coronavirus disease (COVID-19) in London 
A general view outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville 
HEALTH-CORONAVIRUS/BRITAIN-AUTOS
RTX7HC7L 
May 05, 2020 
A tribute to care workers is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in... 
London, United Kingdom 
Outbreak of the coronavirus disease (COVID-19) in London 
A tribute to care workers is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville 
HEALTH-CORONAVIRUS/BRITAIN
RTX7HC7E 
May 05, 2020 
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West... 
London, United Kingdom 
Outbreak of the coronavirus disease (COVID-19) in London 
A tribute to the NHS is seen outside the Glaxo Smith Kline pharmaceutical company headquarters in West London following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 5, 2020. REUTERS/Toby Melville 
HEALTH-CORONAVIRUS/BRITAIN
RTX7H5O6 
May 04, 2020 
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus... 
London, United Kingdom 
Outbreak of the coronavirus disease (COVID-19) in London 
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs 
HEALTH-CORONAVIRUS/BRITAIN
RTX7H5O4 
May 04, 2020 
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus... 
London, United Kingdom 
Outbreak of the coronavirus disease (COVID-19) in London 
General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs 
HEALTH-PHARMACY/
RTS2XT0V 
January 09, 2020 
A box and vials of the drug Shingrix, made by GlaxoSmithKline Pharmaceutical, sit on a counter at a pharmacy... 
Provo, UNITED STATES 
A box and vials of the drug Shingrix, made by GlaxoSmithKline Pharmaceutical, sit on a counter at a pharmacy... 
A box and vials of the drug Shingrix, made by GlaxoSmithKline Pharmaceutical, sit on a counter at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey 
GSK-RESULTS/
RTX7AKVN 
November 26, 2019 
A scientist studies cancer cells inside white blood cells through a microscope at the GlaxoSmithKline... 
STEVENAGE, United Kingdom 
A scientist studies cancer cells inside white blood cells through a microscope at the GSK research centre... 
A scientist studies cancer cells inside white blood cells through a microscope at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKVJ 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKVG 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKVA 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV9 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV7 
November 26, 2019 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre... 
STEVENAGE, United Kingdom 
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV6 
November 26, 2019 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre... 
STEVENAGE, United Kingdom 
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV5 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV4 
November 26, 2019 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre... 
STEVENAGE, United Kingdom 
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV3 
November 26, 2019 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre... 
STEVENAGE, United Kingdom 
A scientist uses a molecular weighing robot during research at the GSK research centre in Stevenage 
A scientist uses a molecular weighing robot during research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV2 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKV1 
November 26, 2019 
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
Scientists look at test tubes containing stem cells at the GSK research centre in Stevenage 
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKUX 
November 26, 2019 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
A scientist prepares stem cells for research at the GSK research centre in Stevenage 
A scientist prepares stem cells for research at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKUR 
November 26, 2019 
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage,... 
STEVENAGE, United Kingdom 
Scientists look at test tubes containing stem cells at the GSK research centre in Stevenage 
Scientists look at test tubes containing stem cells at the GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKUP 
November 26, 2019 
A GSK logo is seen on a flag at a GlaxoSmithKline (GSK) research centre in Stevenage, Britain November... 
STEVENAGE, United Kingdom 
A GSK logo is seen on a flag at a GSK research centre in Stevenage 
A GSK logo is seen on a flag at a GlaxoSmithKline (GSK) research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKSX 
November 26, 2019 
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019.... 
STEVENAGE, United Kingdom 
A GSK logo is seen at the GSK research centre in Stevenage 
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
GSK-RESULTS/
RTX7AKSP 
November 26, 2019 
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019.... 
STEVENAGE, United Kingdom 
A GSK logo is seen at the GSK research centre in Stevenage 
A GlaxoSmithKline (GSK) logo is seen at the GSK research centre in Stevenage, Britain November 26, 2019. REUTERS/Peter Nicholls 
BRITAIN-EU/
RTX6G1D0 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1CX 
October 22, 2018 
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool... 
MONTROSE, United Kingdom 
GlaxoSmithKline's production building is seen in Montrose, Scotland 
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1CV 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1CU 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1CG 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1CB 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1C7 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley... 
Scotland's First Minister Nicola Sturgeon talks with GlaxoSmithKline's (GSK’s) new CEO Emma Walmsley (L) in GSK's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1C5 
October 22, 2018 
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool... 
MONTROSE, United Kingdom 
GlaxoSmithKline's production building is seen in Montrose, Scotland 
GlaxoSmithKline's production building is seen in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
BRITAIN-EU/
RTX6G1BZ 
October 22, 2018 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
MONTROSE, United Kingdom 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose,... 
Scotland's First Minister Nicola Sturgeon tours GlaxoSmithKline's new production building in Montrose, Scotland, Britain October 22, 2018. Andy Buchanan/Pool via REUTERS 
Sort by 
Display 
Items per page 
Page 
of 7